Commentary to the article "Human skin penetration of the major components of Australian tea tree oil applied in its pure form and as a 20% solution in vitro"

被引:1
作者
Cal, Krzysztof [1 ]
机构
[1] Med Acad Gdansk, Dept Pharmaceut Technol, PL-80416 Gdansk, Poland
关键词
skin penetration; stratum corneum; tea tree oil; terpinen-4-ol;
D O I
10.1016/j.ejpb.2008.01.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This note summarises recent studies on skin penetration of terpinen-4-ol, which is the main component of tea tree oil [S.E. Cross, M. Russell, I. Southwell, M.S. Roberts, Human skin penetration of the major components of Australian tea tree oil applied in its pure form and as a 20% solution in vitro, Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2007.10.002 (in press)]. The influence of different experimental models on obtained skin penetration results is discussed. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:838 / 839
页数:2
相关论文
共 7 条
[1]  
Cal K., 2007, International Journal of Essential Oil Therapeutics, V1, P1
[2]   Skin penetration of terpenes from essential oils and topical vehicles [J].
Cal, K .
PLANTA MEDICA, 2006, 72 (04) :311-316
[3]   Effect of physicochemical properties of cyclic terpenes on their ex vivo skin absorption and elimination kinetics [J].
Cal, K ;
Kupiec, K ;
Sznitowska, M .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2006, 41 (02) :137-142
[4]   How does the type of vehicle influence the in vitro skin absorption and elimination kinetics of terpenes? [J].
Cal, K .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2006, 297 (07) :311-315
[5]   Stratum corneum absorption and retention of linalool and terpinen-4-ol applied as gel or oily solution in humans [J].
Cal, Krzysztof ;
Krzyzaniak, Malgorzata .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2006, 42 (03) :265-267
[6]  
CROSS SE, IN PRESS EUR J PHARM
[7]   In vitro studies on release and human skin permeation of Australian tea tree oil (TTO) from topical formulations [J].
Reichling, Juergen ;
Landvatter, Uwe ;
Wagner, Heike ;
Kostka, Karl-Heinz ;
Schaefer, Ulrich F. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 64 (02) :222-228